Scilex Holding Co - 22 Sep 2025 SCHEDULE 13D Report for Semnur Pharmaceuticals, Inc. Common Stock, par value $0.0001

Filing Manager
Scilex Holding Co
Reporting Manager
Scilex Holding Company
Security
Semnur Pharmaceuticals, Inc. Common Stock, par value $0.0001
Shares outstanding
236,018,086 shares
Disclosed Ownership
188,554,849 shares
Ownership
80%
Form type
SCHEDULE 13D
Filing time
26 Sep 2025, 16:10:24 UTC
Date of event
22 Sep 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Scilex Holding Company 80% 188,554,849 500,000 188,054,849 /s/ Henry Ji Henry Ji, Chief Executive Officer and President 0001820190
Scilex, Inc. 77% 181,804,849 0 181,804,849 /s/ Henry Ji Henry Ji, Chief Executive Officer 0002084647